The Food and Drug Administration recently sent a warning letter to Leslie Baumann, MD, a well-known dermatologist and clinical researcher in Miami Beach, citing the doctor for expressing premature enthusiasm in the media about Dysport, an injectable antiwrinkle drug the agency had not yet approved. Baumann's comments in the media in 2007 violated restrictions on drug promotion, according to the letter. The FDA has asked Baumann to explain how she intended to prevent similar violations in the future, the New York Times reports.
